ONPATTRO

Serial Number 87569917
Registration 5591475
702

Registration Progress

Application Filed
Aug 15, 2017
Under Examination
Feb 13, 2018
Approved for Publication
Dec 19, 2017
Published for Opposition
Dec 19, 2017
Registered
Oct 23, 2018

Basic Information

Serial Number
87569917
Registration Number
5591475
Filing Date
August 15, 2017
Registration Date
October 23, 2018
Published for Opposition
December 19, 2017
Drawing Code
3

Status Summary

Current Status
Active
Status Code
702
Status Date
Feb 6, 2025
Registration
Registered
Classes
005

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
675 West Kendall Street
Henri A. Termeer Square
Cambridge, MA 02142

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Sarah Anne Keefe

USPTO Deadlines

Next Renewal Deadline
1203 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-10-23)
Due Date
October 23, 2028
Grace Period Ends
April 23, 2029

Application History

25 events
Date Code Type Description
Feb 6, 2025 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Feb 6, 2025 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Feb 4, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 18, 2024 E815 I TEAS SECTION 8 & 15 RECEIVED
Oct 23, 2023 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 23, 2018 R.PR A REGISTERED-PRINCIPAL REGISTER
Sep 18, 2018 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 15, 2018 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 13, 2018 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Sep 10, 2018 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 14, 2018 IUAF S USE AMENDMENT FILED
Aug 14, 2018 EISU I TEAS STATEMENT OF USE RECEIVED
Aug 4, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 2, 2018 EX1G S SOU EXTENSION 1 GRANTED
Aug 2, 2018 EXT1 S SOU EXTENSION 1 FILED
Aug 2, 2018 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 13, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 19, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 19, 2017 PUBO A PUBLISHED FOR OPPOSITION
Nov 29, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 16, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 16, 2017 DOCK D ASSIGNED TO EXAMINER
Aug 22, 2017 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 21, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 18, 2017 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of transthyretin-mediated amyloidosis; Pharmaceutical preparations for the treatment of familial amyloidotic polyneuropathy
First Use Anywhere: Aug 13, 2018
First Use in Commerce: Aug 13, 2018

Additional Information

Design Mark
The mark consists of the word "ONPATTRO" and a stylized representation of the DNA molecule, between the upper strands of which is a roughly triangular shape.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005